"The high quality care provided at BRCC includes state-of-the-art technologies and treatments delivered in a compassionate and comfortable setting. BRCC’s model of integrated community-based care maximizes patient and family convenience, while offering patients comprehensive care close to home."

During the past decade, Blue Ridge Cancer Care conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 35 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 18 clinical trials were completed. i.e. 90% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Blue Ridge Cancer Care" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "Bristol-Myers Squibb" with 7 trials sponsored, "Seagen Inc." with 6 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Blue Ridge Cancer Care" #1 collaborator was "Amgen" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "US Oncology Research" with 2 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Blue Ridge Cancer Care" are "Non-Small Cell Lung Cancer" (6 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials), "Metastatic Breast Cancer" (5 trials), "Breast Cancer" (3 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Blue Ridge Cancer Care" in a lesser frequency.

Most popular intervention types in "Blue Ridge Cancer Care" are "Drug" (66 trials), "Biological" (6 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (10 trials), "Atezolizumab" (9 trials), "Placebo" (9 trials), "Docetaxel" (6 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Blue Ridge Cancer Care" are 64 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Blue Ridge Cancer Care". undefined are not yet recruiting, 11 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Blue Ridge Cancer Care, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Blue Ridge Cancer Care, 9 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Blue Ridge Cancer Care has several departments that took part in Clinical trials: "Blue Ridge Cancer Care - Roanoke" - 8 trials, "Blue Ridge Cancer Care" - 2 trials